Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650468 · ClinicalTrials.gov registry record · Phase 4
A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 397
- Enrollment target
NCT00650468: Completed Phase 4 study, sponsored by Astellas Pharma.
NCT00650468 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 397 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00650468, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 397 participants
- Enrollment target
Study Summary
A study comparing the early withdrawal of steroids to long-term maintenance steroid therapy in Kidney Transplant Patients receiving Prograf and Cellcept
Interventions
- DRUG tacrolimus
- DRUG CellCept
- DRUG steroids (methylprednisone or prednisone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 397 participants |
| Start Date | 1999-11 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
What the finished NCT00650468 record still lists
NCT00650468 is an interventional study that assigns participants to a tested intervention. The registered 397 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 3 interventions - of which tacrolimus is the first listed.
NCT00650468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00650468 about?
NCT00650468 is a clinical study titled "A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients". A study comparing the early withdrawal of steroids to long-term maintenance steroid therapy in Kidney Transplant Patients receiving Prograf and Cellcept
What is the current status of trial NCT00650468?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 397 participants. The study started on 1999-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00650468?
The interventions under investigation include: tacrolimus (DRUG), CellCept (DRUG), steroids (methylprednisone or prednisone) (DRUG).
Who is sponsoring clinical trial NCT00650468?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00650468's enrollment target sits among peer trials
397 218th of 2000 higher than 1,783 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
- NCT04115254 · 397 participants · NA
Stereotactic Magnetic Resonance Guided Radiation Therapy
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia